Display options
Cite
Zbinden A, Layland SL, Urbanczyk M, et al. Nidogen-1 Mitigates Ischemia and Promotes Tissue Survival and Regeneration. Adv Sci (Weinh). 2020;8(4):2002500doi: 10.1002/advs.202002500.
Zbinden, A., Layland, S. L., Urbanczyk, M., Carvajal Berrio, D. A., Marzi, J., Zauner, M., Hammerschmidt, A., Brauchle, E. M., Sudrow, K., Fink, S., Templin, M., Liebscher, S., Klein, G., Deb, A., Duffy, G. P., Crooks, G. M., Eble, J. A., Mikkola, H. K. A., Nsair, A., Seifert, M., & Schenke-Layland, K. (2021). Nidogen-1 Mitigates Ischemia and Promotes Tissue Survival and Regeneration. Advanced science (Weinheim, Baden-Wurttemberg, Germany), 8(4), 2002500. https://doi.org/10.1002/advs.202002500
Zbinden, Aline, et al. "Nidogen-1 Mitigates Ischemia and Promotes Tissue Survival and Regeneration." Advanced science (Weinheim, Baden-Wurttemberg, Germany) vol. 8,4 (2021): 2002500. doi: https://doi.org/10.1002/advs.202002500
Zbinden A, Layland SL, Urbanczyk M, Carvajal Berrio DA, Marzi J, Zauner M, Hammerschmidt A, Brauchle EM, Sudrow K, Fink S, Templin M, Liebscher S, Klein G, Deb A, Duffy GP, Crooks GM, Eble JA, Mikkola HKA, Nsair A, Seifert M, Schenke-Layland K. Nidogen-1 Mitigates Ischemia and Promotes Tissue Survival and Regeneration. Adv Sci (Weinh). 2020 Dec 21;8(4):2002500. doi: 10.1002/advs.202002500. eCollection 2021 Feb. PMID: 33643791; PMCID: PMC7887579.
Copy Download .nbib Format: NLM
Share it on

Adv Sci (Weinh). 2020 Dec 21;8(4):2002500. doi: 10.1002/advs.202002500. eCollection 2021 Feb.

Nidogen-1 Mitigates Ischemia and Promotes Tissue Survival and Regeneration.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Aline Zbinden, Shannon L Layland, Max Urbanczyk, Daniel A Carvajal Berrio, Julia Marzi, Monika Zauner, Anne Hammerschmidt, Eva M Brauchle, Katrin Sudrow, Simon Fink, Markus Templin, Simone Liebscher, Gerd Klein, Arjun Deb, Garry P Duffy, Gay M Crooks, Johannes A Eble, Hanna K A Mikkola, Ali Nsair, Martina Seifert, Katja Schenke-Layland

Affiliations

  1. Department of Bioengineering Eberhard Karls University Tübingen Tübingen 72076 Germany.
  2. Department of Women's Health Research Institute for Women's Health Eberhard Karls University Tübingen Tübingen 72076 Germany.
  3. Cluster of Excellence iFIT (EXC 2180) "Image-Guided and Functionally Instructed Tumor Therapies" Eberhard Karls University Tübingen Tübingen 72076 Germany.
  4. NMI Natural and Medical Sciences Institute at the University of Tübingen Reutlingen 72770 Germany.
  5. Institute of Medical Immunology Charité Universitätsmedizin Berlin corporate member of Freie Universität Berlin Humboldt-Universität zu Berlin Berlin 10117 Germany.
  6. Charité Universitätsmedizin Berlin Institute of Health (BIH) Center for Regenerative Therapies Berlin (BCRT) Berlin 10178 Germany.
  7. Center for Medical Research Department of Medicine II Eberhard Karls University Tübingen Tübingen 72076 Germany.
  8. Department of Molecular Cell and Developmental Biology UCLA Los Angeles CA 90095 USA.
  9. Eli and Edythe Broad Stem Cell Research Center UCLA Los Angeles CA 90095 USA.
  10. Molecular Biology Institute UCLA Los Angeles CA 90095 USA.
  11. Jonsson Comprehensive Cancer Center UCLA Los Angeles CA 90024 USA.
  12. Department of Medicine/Cardiology Cardiovascular Research Laboratories David Geffen School of Medicine at UCLA Los Angeles CA 90095 USA.
  13. Anatomy and Regenerative Medicine Institute School of Medicine College of Medicine Nursing and Health Sciences National University of Ireland Galway Galway H91TK33 Ireland.
  14. Department of Pathology and Laboratory Medicine, and Pediatrics David Geffen School of Medicine at UCLA UCLA Los Angeles CA 90095 USA.
  15. Institute of Physiological Chemistry and Pathobiochemistry University of Münster Münster 48149 Germany.
  16. DZHK (German Centre for Cardiovascular Research) partner site Berlin Berlin 10117 Germany.

PMID: 33643791 PMCID: PMC7887579 DOI: 10.1002/advs.202002500

Abstract

Ischemia impacts multiple organ systems and is the major cause of morbidity and mortality in the developed world. Ischemia disrupts tissue homeostasis, driving cell death, and damages tissue structure integrity. Strategies to heal organs, like the infarcted heart, or to replace cells, as done in pancreatic islet

© 2020 The Authors. Advanced Science published by Wiley‐VCH GmbH.

Keywords: diabetes; ischemia; myocardial infarction; nidogen‐1; pancreatic β‐cells

Conflict of interest statement

A.Z., S.L.L., G.P.D., and K.S.‐L. are inventors on patent application EP19154849.4 associated with this work and owned by the University Tübingen. S.L.L., M.Z., and K.S.‐L. are inventors on patents (E

References

  1. FASEB J. 2012 Sep;26(9):3637-48 - PubMed
  2. Nature. 2008 May 22;453(7194):524-8 - PubMed
  3. Exp Mol Med. 2013 Aug 23;45:e37 - PubMed
  4. Eur Heart J. 2016 Mar 14;37(11):873-9 - PubMed
  5. J Biophotonics. 2020 Dec;13(12):e202000375 - PubMed
  6. Nature. 2017 Jul 13;547(7662):179-184 - PubMed
  7. Adv Funct Mater. 2018 May 24;28(21):1800618 - PubMed
  8. Biochemistry. 1998 Aug 4;37(31):10945-55 - PubMed
  9. Tissue Eng Part A. 2018 Jan;24(1-2):57-67 - PubMed
  10. Biomaterials. 2011 Apr;32(11):2748-56 - PubMed
  11. Cardiovasc Res. 2011 Oct 1;92(1):19-28 - PubMed
  12. Nat Med. 2011 Nov 07;17(11):1391-401 - PubMed
  13. Stem Cells Dev. 2009 Jul-Aug;18(6):919-28 - PubMed
  14. Dev Biol. 1994 Jul;164(1):197-206 - PubMed
  15. EMBO J. 2012 Jan 18;31(2):429-42 - PubMed
  16. J Biol Chem. 1981 May 25;256(10):5209-14 - PubMed
  17. Nat Rev Urol. 2019 Jul;16(7):389-390 - PubMed
  18. Circulation. 1996 Oct 1;94(7):1506-12 - PubMed
  19. Matrix Biol. 2020 Jan;85-86:205-220 - PubMed
  20. Adv Drug Deliv Rev. 2017 Dec 1;122:74-83 - PubMed
  21. Biomaterials. 2012 Jul;33(21):5259-66 - PubMed
  22. Curr Biol. 2017 Mar 20;27(6):R207-R211 - PubMed
  23. Nat Rev Cardiol. 2018 Nov;15(11):672-684 - PubMed
  24. Tissue Eng Part A. 2020 Apr;26(7-8):387-399 - PubMed
  25. EMBO J. 1991 Nov;10(11):3137-46 - PubMed
  26. Nature. 2018 May;557(7705):351-358 - PubMed
  27. Development. 2017 Dec 1;144(23):4261-4270 - PubMed
  28. Trends Endocrinol Metab. 2008 Dec;19(10):349-55 - PubMed
  29. Development. 2010 Nov;137(21):3591-601 - PubMed
  30. Nat Rev Mol Cell Biol. 2014 Dec;15(12):786-801 - PubMed
  31. Sci Rep. 2017 Aug 29;7(1):9801 - PubMed
  32. J Cell Mol Med. 2017 Aug;21(8):1572-1583 - PubMed
  33. J Korean Med Sci. 2009 Aug;24(4):654-9 - PubMed
  34. Circ J. 2012;76(11):2513-20 - PubMed
  35. Cell Adhes Commun. 1998 Mar;5(3):237-48 - PubMed
  36. J Cell Sci. 2001 Apr;114(Pt 8):1567-77 - PubMed
  37. Acta Biomater. 2013 Sep;9(9):8140-8 - PubMed
  38. Circ Res. 2011 Aug 5;109(4):360-4 - PubMed
  39. Nat Mater. 2017 Oct;16(10):1038-1046 - PubMed
  40. Nat Med. 2007 Aug;13(8):962-9 - PubMed
  41. J Thorac Dis. 2017 Mar;9(Suppl 1):S52-S63 - PubMed
  42. Nat Commun. 2016 Sep 23;7:12852 - PubMed
  43. Sci Transl Med. 2013 Feb 20;5(173):173ra25 - PubMed
  44. Science. 1995 Nov 24;270(5240):1326-31 - PubMed
  45. Nat Commun. 2020 Jan 30;11(1):600 - PubMed
  46. Development. 2013 Jun;140(11):2345-53 - PubMed
  47. Dev Cell. 2015 Aug 24;34(4):387-99 - PubMed
  48. Oncoimmunology. 2018 Jul 11;7(9):e1470730 - PubMed
  49. Development. 2019 Jan 16;146(2): - PubMed
  50. J Cell Sci. 2010 Dec 15;123(Pt 24):4195-200 - PubMed
  51. Stem Cells. 2008 Jun;26(6):1537-46 - PubMed
  52. Biomaterials. 2013 Oct;34(30):7401-7 - PubMed
  53. FASEB J. 1995 Nov;9(14):1401-10 - PubMed
  54. Adv Funct Mater. 2019 Jan 24;29(4): - PubMed
  55. Sci Rep. 2018 Jan 8;8(1):110 - PubMed
  56. J Mater Chem B. 2018 Oct 28;6(40):6399-6412 - PubMed
  57. J Clin Invest. 2017 May 1;127(5):1600-1612 - PubMed
  58. Nat Med. 2012 Jul 06;18(7):1028-40 - PubMed
  59. J Biol Chem. 1999 Feb 19;274(8):5038-46 - PubMed
  60. Nat Cell Biol. 2019 Feb;21(2):263-274 - PubMed

Publication Types